Comparing the performance of risk stratification scores in Brugada syndrome: a multi-centre study

Introduction: The management of Brugada Syndrome (BrS) patients at intermediate risk of arrhythmic events remains controversial. The present study evaluated the predictive performance of different risk scores in an Asian BrS population and its intermediate risk subgroup. Methods: This is a retrospective territory-wide cohort study of consecutive patients diagnosed with BrS from January 1st, 1997 to June 20th, 2020 in Hong Kong. The primary outcome is sustained ventricular tachyarrhythmias. A novel predictive score was developed. Machine learning-based nearest neighbor and Gaussian Naive Bayes models were also developed. The area under the receiver operator characteristic (ROC) curve (AUC) was compared between the different scores. Results: The cohort consists of 548 consecutive BrS patients (7% female, age at diagnosis: 50+/-16 years old, follow-up duration: 84+/-55 months). For risk stratification in the whole BrS cohort, the score developed by Sieira et al. showed the best performance with an AUC of 0.805, followed by the Shanghai score (0.698), and the scores by Okamura et al. (0.667), Delise et al. (0.661), Letsas et al. (0.656) and Honarbakhsh et al. (0.592). A novel risk score was developed based on variables and weighting from the best performing score (the Sieira score), with the inclusion of additional variables significant on univariable Cox regression (arrhythmias other than ventricular tachyarrhythmias, early repolarization pattern in the peripheral leads, aVR sign, S-wave in lead I and QTc [≥]436 ms). This score has the highest AUC of 0.855 (95% CI: 0.808-0.901). The Gaussian Naive Bayes model demonstrated the best performance (AUC: 0.97) compared to logistic regression and nearest neighbor models. Conclusion: The inclusion of investigation results and more complex models are needed to improve the predictive performance of risk scores in the intermediate risk BrS population.

[1]  C. Antzelevitch,et al.  Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants. , 2021, Journal of the American College of Cardiology.

[2]  Qingpeng Zhang,et al.  Territory-wide cohort study of Brugada syndrome in Hong Kong: predictors of long-term outcomes using random survival forests and non-negative matrix factorisation , 2021, Open Heart.

[3]  G. Parati,et al.  Brugada syndrome and syncope: a practical approach for diagnosis and treatment. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  F. Sacher,et al.  Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome. , 2020, European heart journal.

[5]  P. Lambiase,et al.  A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). , 2020, JACC. Clinical electrophysiology.

[6]  Jason D. Roberts,et al.  The evolution of gene‐guided management of inherited arrhythmia syndromes: Peering beyond monogenic paradigms towards comprehensive genomic risk scores , 2020, Journal of cardiovascular electrophysiology.

[7]  G. Bazoukis,et al.  Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach. , 2019, Europace.

[8]  J. Brugada,et al.  The role of clinical assessment and electrophysiology study in Brugada syndrome patients with syncope. , 2019, American heart journal.

[9]  S. Priori,et al.  Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  S. Priori,et al.  Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome. , 2019, Journal of the American College of Cardiology.

[11]  Yanwei Xing,et al.  Pooled Analysis of Risk Stratification of Spontaneous Type 1 Brugada ECG: Focus on the Influence of Gender and EPS , 2019, Front. Physiol..

[12]  J. Brugada,et al.  Present Status of Brugada Syndrome: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[13]  H. Morita,et al.  Shanghai Score System for Diagnosis of Brugada Syndrome: Validation of the Score System and System and Reclassification of the Patients. , 2018, JACC. Clinical electrophysiology.

[14]  A. Baranchuk,et al.  High risk electrocardiographic markers in Brugada syndrome , 2018, International journal of cardiology. Heart & vasculature.

[15]  A. Baranchuk,et al.  Prognosis, risk stratification, and management of asymptomatic individuals with Brugada syndrome: A systematic review , 2017, Pacing and clinical electrophysiology : PACE.

[16]  F. Gaita,et al.  Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope. , 2017, International journal of cardiology.

[17]  P. Brugada,et al.  A score model to predict risk of events in patients with Brugada Syndrome , 2017, European heart journal.

[18]  T. Ngarmukos,et al.  Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis. , 2017, Acta Cardiologica Sinica.

[19]  P. Ellinor,et al.  Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis , 2016, Circulation.

[20]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[21]  H. Morita,et al.  Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[22]  Dan M Roden,et al.  Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death , 2013, Nature Genetics.

[23]  S. Priori,et al.  [Risk stratification in Brugada syndrome]. , 2011, Giornale italiano di cardiologia.

[24]  Jonathan M. Garibaldi,et al.  A 'non-parametric' version of the naive Bayes classifier , 2011, Knowl. Based Syst..

[25]  M. Horie,et al.  Risk determinants in individuals with a spontaneous type 1 Brugada ECG. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[26]  F. Gaita,et al.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach , 2010, European heart journal.

[27]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[28]  B. Park,et al.  Choice of neighbor order in nearest-neighbor classification , 2008, 0810.5276.

[29]  H. Huikuri,et al.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge , 2016, Journal of arrhythmia.